Literature DB >> 26919073

The clinicopathological features of pituicytoma and the differential diagnosis of sellar glioma.

Junmei Wang1, Zhaoxia Liu1, Jiang Du1, Yun Cui1, Jingyi Fang1, Li Xu1, Guilin Li1.   

Abstract

Pituicytoma is rare and difficult to diagnose. This study explored the clinicopathological features, immunophenotype and differential diagnosis of pituicytoma. We compared 11 cases of pituicytoma and 26 cases of sellar glioma (16 pilocytic astrocytomas, four diffuse astrocytomas, three pilomyxoid astrocytomas, and three third ventricle chordoid gliomas). The 11 pituicytoma cases involved six men and five women (age: 33-65 years). Three of the 11 patients experienced recurrence due to a residual tumor, and one patient underwent three surgeries during a 6-month period. Imaging findings revealed tumors were in the intrasellar region (four cases), suprasellar region (four cases) and intra-suprasellar regions (three cases). The tumor diameters were 1.3-3.8 cm, and the preoperative diagnoses were pituitary adenoma, craniopharyngioma and meningioma. The tumors were solid and contained spindle or slightly chubby cells that were densely arranged with visible cleft-like or expanded sinusoid structures. The cells had vague boundaries, circular nuclei, fine chromatin, and a small nucleolus. Immunohistochemical staining of the pituicytomas revealed positive expression of thyroid transcription factor-1 (TTF-1) and S-100 protein (S-100), positive focal expression of glial GFAP;(five of 11 cases), and negative oligodendrocyte transcription factor 2 (Olig2), CD34 and neurofilament expression. The Ki67 index was 6% in one case and 1-2% in the other cases. Unlike pituicytoma, most sellar glioma cases exhibited GFAP and Olig2 expression, and negative TTF-1 expression. Third ventricle chordoid gliomas expressed TTF-1, GFAP and CD34, and were negative for Olig2. Our results indicate that pituicytoma typically involves dense arrangements of spindle or slightly chubby cells. The morphology is occasionally atypical, with ependymoma-like or meningioma-like structures, and occasionally exhibits pilomyxoid degeneration. Abundant sinusoids are characteristic of hemorrhagic tumors. The dense spindle cell arrangement is a relatively specific morphology, and staining for GFAP, TTF-1, Olig2 and CD4 may help differentiate pituicytoma from sellar glioma.
© 2016 Japanese Society of Neuropathology.

Entities:  

Keywords:  TTF-1; immunohistochemistry; pituicytoma; sellar glioma; third ventricle chordoid glioma

Mesh:

Substances:

Year:  2016        PMID: 26919073     DOI: 10.1111/neup.12291

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  9 in total

1.  Pituicytoma-An outlook on possible targeted therapies.

Authors:  Klaus Christian Mende; Jakob Matschke; Till Burkhardt; Wolfgang Saeger; Rolf Buslei; Michael Buchfelder; Rudolf Fahlbusch; Manfred Westphal; Jörg Flitsch
Journal:  CNS Neurosci Ther       Date:  2017-05-28       Impact factor: 5.243

Review 2.  Primary tumors of the posterior pituitary: A systematic review.

Authors:  Fernando Guerrero-Pérez; Agustina Pia Marengo; Noemi Vidal; Pedro Iglesias; Carles Villabona
Journal:  Rev Endocr Metab Disord       Date:  2019-06       Impact factor: 6.514

3.  Surgical management of pituicytomas: a single-center case series.

Authors:  Amine Trifa; Steven Knafo; Ahmed Maatoug; Matei Militaru; Razvan Copaciu; Nozar Aghakhani; Fabrice Parker
Journal:  Acta Neurol Belg       Date:  2022-03-17       Impact factor: 2.396

4.  Detection of tumor-specific DNA methylation markers in the blood of patients with pituitary neuroendocrine tumors.

Authors:  Grayson A Herrgott; Karam P Asmaro; Michael Wells; Thais S Sabedot; Tathiane M Malta; Maritza S Mosella; Kevin Nelson; Lisa Scarpace; Jill S Barnholtz-Sloan; Andrew E Sloan; Warren R Selman; Ana C deCarvalho; Laila M Poisson; Abir Mukherjee; Adam M Robin; Ian Y Lee; James Snyder; Tobias Walbert; Mark Rosenblum; Tom Mikkelsen; Arti Bhan; John Craig; Steven Kalkanis; Jack Rock; Houtan Noushmehr; Ana Valeria Castro
Journal:  Neuro Oncol       Date:  2022-07-01       Impact factor: 13.029

5.  Histologic, immunohistochemical, and molecular features of pituicytomas and atypical pituicytomas.

Authors:  Angela N Viaene; Edward B Lee; Jason N Rosenbaum; Ilya M Nasrallah; MacLean P Nasrallah
Journal:  Acta Neuropathol Commun       Date:  2019-05-02       Impact factor: 7.801

6.  Posterior pituitary tumours: patient outcomes and determinants of disease recurrence or persistence.

Authors:  Liza Das; Kim Vaiphei; Ashutosh Rai; Chirag Kamal Ahuja; Paramjeet Singh; Ishani Mohapatra; Rajesh Chhabra; Anil Bhansali; Bishan Dass Radotra; Ashley B Grossman; Márta Korbonits; Pinaki Dutta
Journal:  Endocr Connect       Date:  2021-04       Impact factor: 3.335

7.  Malignant Endo-suprasellar Glioma: A Case Report and a Brief Review of the Literature.

Authors:  Marina Berkovskaya; Andrey Y Grigoriev; Kirill N Zhuravlev; Valentin V Fadeev
Journal:  Int J Endocrinol Metab       Date:  2022-03-09

8.  Clinical features, radiological profiles, pathological features and surgical outcomes of pituicytomas: a report of 11 cases and a pooled analysis of individual patient data.

Authors:  Jian-Hua Cheng; Ding Nie; Bin Li; Song-Bai Gui; Chu-Zhong Li; Ya-Zhuo Zhang; Luigi Maria Cavallo; Peng Zhao
Journal:  Mil Med Res       Date:  2021-07-02

9.  Epithelioid pituicytoma: An unusual case report.

Authors:  Eduardo de Arnaldo Silva Vellutini; Pedro Henrique Petit Becker; Luis Felipe Godoy; Nicolau Faria Correia Guerreiro; Romulo Loss Mattedi; Matheus Fernandes de de Oliveira
Journal:  Surg Neurol Int       Date:  2018-07-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.